Search Results - "Mikkilineni, A"

BMS-201620: a selective beta 3 agonist by Washburn, W.N., Sun, C.-Q., Bisacchi, G., Wu, G., Cheng, P.T., Sher, P.M., Ryono, D., Gavai, A.V., Poss, K., Girotra, R.N., McCann, P.J., Mikkilineni, A.B., Dejneka, T.C., Wang, T.C., Merchant, Z., Morella, M., Arbeeny, C.M., Harper, T.W., Slusarchyk, D.A., Skwish, S., Russell, A.D., Allen, G.T., Tesfamariam, B., Frohlich, B.H., Abboa-Offei, B.E., Cap, M., Waldron, T.L., George, R.J., Young, D., Dickinson, K.E., Seymour, A.A.

“…Graphic A series of N-(4-hydroxy-3-methylsulfonanilidoethanol)arylglycinamides were prepared and evaluated for their human β 3 adrenergic receptor agonist…”
Get full text

Arylpropanolamines : Selective β3 agonists arising from strategies to mitigate phase I metabolic transformations by WASHBURN, W. N, HARPER, T. W, DEJNEKA, T, AHMED, S, CARINGAL, Y, HANGELAND, J, ZHANG, M, CHENG, P. T. W, RUSSELL, A. D, SKWISH, S, SLUSARCHYK, D. A, ALLEN, G. T, WU, G, FROHLICH, B. H, ABBOA-OFFEI, B. E, CAP, M, WALDRON, T. L, GEORGE, R. J, TESFAMARIAM, B, DICKINSON, K. E, SEYMOUR, A. A, SHER, P. M, GODFREY, J. D, MCCANN, P, GIROTRA, R, SHAO, C, ZHANG, H, GAVAI, A, MIKKILINENI, A

Get full text

Beta 3 agonists. Part 1: evolution from inception to BMS-194449 by Washburn, W.N., Sher, P.M., Poss, K.M., Girotra, R.N., McCann, P.J., Gavai, A.V., Mikkilineni, A.B., Mathur, A., Cheng, P., Dejneka, T.C., Sun, C.Q., Wang, T.C., Harper, T.W., Russell, A.D., Slusarchyk, D.A., Skwish, S., Allen, G.T., Hillyer, D.E., Frohlich, B.H., Abboa-Offei, B.E., Cap, M., Waldron, T.L., George, R.J., Tesfamariam, B., Ciosek, C.P., Ryono, D., Young, D.A., Dickinson, K.E., Seymour, A.A., Arbeeny, C.M., Gregg, R.E.

“…Screening of the BMS collection identified 4-hydroxy-3-methylsulfonanilidoethanolamines as full beta 3 agonists. Substitution of the ethanolamine nitrogen with…”
Get full text

BMS-196085 : A potent and selective full agonist of the human β3 adrenergic receptor by GAVAI, A. V, SHER, P. M, WANG, T. C, SUN, C. Q, SLUSARCHYK, D. A, SKWISH, S, ALLEN, G. T, HILLYER, D. E, FROHLICH, B. H, ABBOA-OFFEI, B. E, CAP, M, WALDRON, T. L, MIKKILINENI, A. B, GEORGE, R. J, TESFAMARIAM, B, HARPER, T. W, CIOSEK, C. P, YOUNG, D. A, DICKINSON, K. E, SEYMOUR, A. A, ARBEENY, C. M, WASHBURN, W. N, POSS, K. M, MCCANN, P. J, GIROTRA, R. N, FISHER, L. G, WU, G, BEDNARZ, M. S, MATHUR, A

Get full text

Tubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase by Mamber, S W, Mikkilineni, A B, Pack, E J, Rosser, M P, Wong, H, Ueda, Y, Forenza, S

“…Paclitaxel (taxol) phosphate derivatives BMY46366, BMY-46489, BMS180661 and BMS180820 were used to determine the ability of alkaline phosphatase to convert…”
Get more information

Scanner Identification Using Feature-Based Processing and Analysis by Khanna, N., Mikkilineni, A.K., Delp, E.J.

“…Digital images can be obtained through a variety of sources including digital cameras and scanners. In many cases, the ability to determine the source of a…”
Get full text

BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor by Gavai, A V, Sher, P M, Mikkilineni, A B, Poss, K M, McCann, P J, Girotra, R N, Fisher, L G, Wu, G, Bednarz, M S, Mathur, A, Wang, T C, Sun, C Q, Slusarchyk, D A, Skwish, S, Allen, G T, Hillyer, D E, Frohlich, B H, Abboa-Offei, B E, Cap, M, Waldron, T L, George, R J, Tesfamariam, B, Harper, T W, Ciosek, Jr, C P, Young, D A, Dickinson, K E, Seymour, A A, Arbeeny, C M, Washburn, W N

“…A series of 4-hydroxy-3-methylsulfonanilido-1,2-diarylethylamines were prepared and evaluated for their human beta(3) adrenergic receptor agonist activity. SAR…”
Get full text

Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations by Washburn, W N, Harper, T W, Wu, G, Godfrey, J D, McCann, P, Girotra, R, Shao, C, Zhang, H, Gavai, A, Mikkilineni, A, Dejneka, T, Ahmed, S, Caringal, Y, Hangeland, J, Zhang, M, Cheng, P T W, Russell, A D, Skwish, S, Slusarchyk, D A, Allen, G T, Frohlich, B H, Abboa-Offei, B E, Cap, M, Waldron, T L, George, R J, Tesfamariam, B, Dickinson, K E, Seymour, A A, Sher, P M

“…Utilization of N-substituted-4-hydroxy-3-methylsulfonanilidoethanolamines 1 as selective beta(3) agonists is complicated by their propensity to undergo…”
Get full text

Arylpropanolamines: Selective beta sub(3) agonists arising from strategies to mitigate phase I metabolic transformations by Washburn, W N, Harper, T W, Wu, G, Godfrey, J D, McCann, P, Girotra, R, Shao, C, Zhang, H, Gavai, A, Mikkilineni, A, Dejneka, T, Ahmed, S, Caringal, Y, Hangeland, J, Zhang, M, Cheng, PTW, Russell, AD, Skwish, S, Slusarchyk, DA, Allen, G T, Frohlich, B H, Abboa-Offei, B E, Cap, M, Waldron, T L, George, R J, Tesfamariam, B, Dickinson, KE, Seymour, A A, Sher, P M

“…Utilization of N-substituted-4-hydroxy-3-methylsulfonanilidoethanolamines 1 as selective beta sub(3) agonists is complicated by their propensity to undergo…”
Get full text

Arylpropanolamines: Selective β 3 agonists arising from strategies to mitigate phase I metabolic transformations by Washburn, W.N., Harper, T.W., Wu, G., Godfrey, J.D., McCann, P., Girotra, R., Shao, C., Zhang, H., Gavai, A., Mikkilineni, A., Dejneka, T., Ahmed, S., Caringal, Y., Hangeland, J., Zhang, M., Cheng, P.T.W., Russell, A.D., Skwish, S., Slusarchyk, D.A., Allen, G.T., Frohlich, B.H., Abboa-Offei, B.E., Cap, M., Waldron, T.L., George, R.J., Tesfamariam, B., Dickinson, K.E., Seymour, A.A., Sher, P.M.

“…Utilization of N-substituted-4-hydroxy-3-methylsulfonanilidoethanolamines 1 as selective β 3 agonists is complicated by their propensity to undergo metabolic…”
Get full text

Printer and scanner forensics by Pei-Ju Chiang, Khanna, N., Mikkilineni, A., Segovia, M.V.O., Sungjoo Suh, Allebach, J., Chiu, G., Delp, E.

“…Contrary to popular opinion, the use of paper in our society will not disappear during the foreseeable future. In fact, paper use continues to grow rather than…”
Get full text

The chemistry of L-ascorbic and D-isoascorbic acids. II: R and S glyceraldehydes from a common intermediate by MIKKILINENI, A. B, KUMAR, P, ABUSHANAB, E

Get full text

Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists by Gavai, Ashvinikumar V., Vaz, Roy J., Mikkilineni, Amarendra B., Roberge, Jacques Y., Liu, Yalei, Lawrence, R. Michael, Corte, James R., Yang, Wu, Bednarz, Mark, Dickson, John K., Ma, Zhengping, Seethala, Ramakrishna, Feyen, Jean H.M.

“…The synthesis and structure–activity relationship study of a novel family of calcium-sensing receptor antagonists are reported. A 3D quantitative…”
Get full text

The chemistry of L-ascorbic and D-isoascorbic acids. I: The preparation of chiral butanetriols and -tetrols by ABUSHANAB, E, PURUSHOTHAM VEMISHETTI, LEIBY, R. W, SINGH, H. K, MIKKILINENI, A. B, WU, D. C.-J, RACHA SAIBABA, PANZICA, R. P

Get full text

5'-deoxy-5'-methylthioadenosine phosphorylase--V. Acycloadenosine derivatives as inhibitors of the enzyme by Savarese, T M, Harrington, S, Nakamura, C, Chen, Z H, Kumar, P, Mikkilineni, A, Abushanab, E, Chu, S H, Parks, Jr, R E

“…Various adenosine acyclonucleoside derivatives were tested as inhibitors of 5'-deoxy-5'-methylthioadenosine (MeSAdo) phosphorylase, an enzyme involved in the…”
Get more information

Novel, water-soluble phosphate derivatives of 2′-ethoxy carbonylpaclitaxel as potential prodrugs of paclitaxel: Synthesis and antitumor evaluation by Ueda, Yasutsugu, Matiskella, John D., Mikkilineni, Amarendra B., Farina, Vittorio, Knipe, Jay O., Rose, William C., Casazza, Anna Maria, Vyas, Dolatrai M.

“…Three new phosphate derivatives of paclitaxel-2′-ethylcarbonate 4a, 4b, and 4c, have been synthesized and evaluated for in vivo antitumor activity. All were…”
Get full text

The chemistry of L-ascorbic and D-isoascorbic acids. 2. R and S glyceraldehydes from a common intermediate by Mikkilineni, Amarendra B, Kumar, Praveen, Abushanab, Elie

Get full text